Effect of Zoledronate on the Expression of Vascular Endothelial Growth Factor-A by Articular Chondrocytes and Synovial Cells: An in Vitro Study

키워드

참고문헌 (23)

1. Brandt KD., "Etiopathogenesis of osteoarthritis", Rheum Dis Clin North Am., 34, pp.531~559 (2008)
2. Goldring MB., "Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis", Ann N Y Acad Sci., 1192, pp.230~237 (2010)
3. Krasnokutsky S., "Current concepts in the pathogenesis of osteoarthritis", Osteoarthritis Cartilage., 16(Suppl 3), pp.S1~3 (2008)
4. Ashraf S., "Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis", Arthritis Rheum., 63, pp.2700~2710 (2011)
5. Mapp PI., "Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis", Nat Rev Rheumatol., 8, pp.390~398 (2012)
6. Jansen H., "Detection of vascular endothelial growth factor (VEGF) in moderate osteoarthritis in a rabbit model", Ann Anat., 194, pp.452~456 (2012)
7. Murata M., "The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis?", Osteoarthritis Cartilage., 16, pp.279~286 (2008)
8. Broadhead ML., "The pathophysiological role of PEDF in bone diseases", Curr Mol Med., 10, pp.296~301 (2010)
9. Fan W., "The ratio of VEGF", PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization, 2011, pp.81, 181~191
10. Tong JP., "Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions", Clin Biochem., 39, pp.267~276 (2006)
11. Evans KD., "Alendronate inhibits VEGF expression in growth plate chondrocytes by acting on the mevalonate pathway", Open Orthop J., 3, pp.83~88 (2009)
12. Kim MS., "Effects of alendronate on a disintegrin and metalloproteinase with thrombospondin motifs expression in the developing epiphyseal cartilage in rats", Anat Histol Embryol., 38, pp.154~160 (2009)
13. Ravosa MJ., "Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts", Arch Oral Biol., 56, pp.491~498 (2011)
14. Melinte R., "VEGF and CD31 expression in arthritic synovium and cartilage of human knee joints", Rom J Morphol Embryol., 53, pp.911~915 (2012)
15. Zhang S., "Expression of VEGF-receptors in TMJ synovium of rabbits with experimentally induced internal derangement", Br J Oral Maxillofac Surg., 51, pp.69~73 (2013)
16. Pasternak B., "Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics", Acta Orthop., 80, pp.693~703 (2009)
17. Choi ST., "Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model", Clin Rheumatol., 28, pp.333~337 (2009)
18. Sekimoto T., "Effect of direct angiogenesis inhibition in rheumatoid arthritis using a soluble vascular endothelial growth factor receptor 1 chimeric protein", J Rheumatol., 29, pp.240~245 (2002)
19. Di Salvatore M., "Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line", Cell Prolif., 44, pp.139~146 (2011)
20. Osterman T., "Effect of clodronate on established adjuvant arthritis", Rheumatol Int., 14, pp.139~147 (1994)
21. Le Goff B., "Pharmacodynamics of bisphosphonates in arthritis", Expert Rev Clin Pharmacol., 4, pp.633~641 (2011)
22. Kang JH., "Alendronate affects cartilage resorption by regulating vascular endothelial growth factor expression in rats", Anat Rec (Hoboken)., 293, pp.786~793 (2010)
23. Van Offel JF., "Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes", Ann Rheum Dis., 61, pp.925~928 (2002)

관련 논문AI추천